Detalhe da pesquisa
1.
NASH limits anti-tumour surveillance in immunotherapy-treated HCC.
Nature
; 592(7854): 450-456, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33762733
2.
Navigating the landscape of liver cancer management: Study designs in clinical trials and clinical practice.
J Hepatol
; 80(6): 957-966, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38307346
3.
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours.
J Hepatol
; 80(3): 431-442, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37972660
4.
The rapidly evolving landscape of HCC: Selecting the optimal systemic therapy.
Hepatology
; 2023 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37695554
5.
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study.
BMC Cancer
; 24(1): 436, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38589856
6.
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.
Lancet Oncol
; 24(12): 1411-1422, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951222
7.
Combination immunotherapy for hepatocellular carcinoma.
J Hepatol
; 79(2): 506-515, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36933770
8.
Risk of Cancer in Inflammatory Bowel Diseases: Umbrella Review and Reanalysis of Meta-analyses.
Gastroenterology
; 163(3): 671-684, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35643170
9.
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study.
Hepatology
; 76(4): 1000-1012, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35313048
10.
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.
Liver Int
; 43(3): 695-707, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36577703
11.
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data.
Liver Int
; 43(8): 1803-1812, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37452505
12.
Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer).
Future Oncol
; 19(38): 2505-2516, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37671641
13.
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(8): 995-1008, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35798016
14.
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score.
J Hepatol
; 76(2): 353-363, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34648895
15.
T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma.
J Hepatol
; 77(2): 397-409, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35367533
16.
Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child-Pugh B liver function at study week 8: a retrospective analysis of the CELESTIAL randomised controlled trial.
BMC Cancer
; 22(1): 377, 2022 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35397508
17.
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma.
Liver Int
; 42(11): 2538-2547, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35986902
18.
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study.
Liver Int
; 42(8): 1891-1901, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35608939
19.
Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study.
Br J Cancer
; 124(2): 407-413, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33071284
20.
Systemic treatment of hepatocellular carcinoma: An EASL position paper.
J Hepatol
; 75(4): 960-974, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34256065